These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 687588)

  • 1. Binding of low-affinity and high-affinity heparin to antithrombin. Ultraviolet difference spectroscopy and circular dichroism studies.
    Nordenman B; Björk I
    Biochemistry; 1978 Aug; 17(16):3339-44. PubMed ID: 687588
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence by chemical modification for the involvement of one or more tryptophanyl residues of bovine antithrombin in the binding of high-affinity heparin.
    Björk I; Nordling K
    Eur J Biochem; 1979 Dec; 102(2):497-502. PubMed ID: 527591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular dichroism spectroscopy of heparin-antithrombin interactions.
    Stone AL; Beeler D; Oosta G; Rosenberg RD
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7190-4. PubMed ID: 6961402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ionic strength and pH on the interaction between high-affinity heparin and antithrombin.
    Nordenman B; Björk I
    Biochim Biophys Acta; 1981 Feb; 672(3):227-38. PubMed ID: 7213813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a heparin-induced conformational change on antithrombin III.
    Villaneuva GB; Danishefsky I
    Biochem Biophys Res Commun; 1977 Jan; 74(2):803-9. PubMed ID: 836327
    [No Abstract]   [Full Text] [Related]  

  • 6. The binding of 1-anilino-8-naphthalenesulfonate, heparin, salicylate and caprylate by human antithrombin III.
    Einarsson R
    Biochim Biophys Acta; 1976 Sep; 446(1):124-33. PubMed ID: 974107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies.
    Nordenman B; Danielsson A; Björk I
    Eur J Biochem; 1978 Sep; 90(1):1-6. PubMed ID: 710412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of low-affinity and high-affinity heparin to antithrombin. Competition for the same binding site on the protein.
    Danielsson A; Björk I
    Eur J Biochem; 1978 Sep; 90(1):7-12. PubMed ID: 710423
    [No Abstract]   [Full Text] [Related]  

  • 9. Tryptophan residue at the heparin binding site in antithrombin III.
    Villaneuva GB; Perret V; Danishefsky I
    Arch Biochem Biophys; 1980 Aug; 203(1):453-7. PubMed ID: 7406509
    [No Abstract]   [Full Text] [Related]  

  • 10. Conformational changes accompanying the binding of antithrombin III to thrombin.
    Villanueva G; Danishefsky I
    Biochemistry; 1979 Mar; 18(5):810-7. PubMed ID: 420817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the domain structure of antithrombin III. Tentative localization of the heparin binding region using 1H NMR spectroscopy.
    Gettins P; Wooten EW
    Biochemistry; 1987 Jul; 26(14):4403-8. PubMed ID: 3663595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The size and shape of human and bovine antithrombin III.
    Nordenman B; Nyström C; Björk I
    Eur J Biochem; 1977 Aug; 78(1):195-203. PubMed ID: 410640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
    Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence.
    Sanchez J; Elgue G; Riesenfeld J; Olsson P
    J Biomed Mater Res; 1995 May; 29(5):655-61. PubMed ID: 7622551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stopped-flow circular dichroism: a rapid kinetic study of the binding of a sulphonamide drug to bovine carbonic anhydrase.
    Bayley P; Anson M
    Biochem Biophys Res Commun; 1975 Feb; 62(3):717-22. PubMed ID: 804309
    [No Abstract]   [Full Text] [Related]  

  • 17. Denaturation behavior of antithrombin in guanidinium chloride. Irreversibility of unfolding caused by aggregation.
    Fish WW; Danielsson A; Nordling K; Miller SH; Lam CF; Björk I
    Biochemistry; 1985 Mar; 24(6):1510-7. PubMed ID: 3986191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A; Björk I
    Biochem J; 1981 Feb; 193(2):427-33. PubMed ID: 7305940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Arg46 and Arg47 of antithrombin in heparin binding.
    Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugar-induced change in near ultraviolet circular dichroism of alpha -crystallin.
    Liang J; Chakrabarti B
    Biochem Biophys Res Commun; 1981 Sep; 102(1):180-9. PubMed ID: 7306146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.